# Supplementation of 500mg Trans-resveratrol Within Hypoxic and Normoxic Conditions, in Healthy Humans.

> **NCT03100019** · NA · COMPLETED · sponsor: **Northumbria University** · enrollment: 24 (actual)

## Conditions studied

- Hypoxia, Brain

## Interventions

- **DIETARY_SUPPLEMENT:** Resveratrol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03100019
- **Lead sponsor:** Northumbria University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-13
- **Primary completion:** 2015-04-30
- **Final completion:** 2015-04-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03100019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03100019, "Supplementation of 500mg Trans-resveratrol Within Hypoxic and Normoxic Conditions, in Healthy Humans.". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03100019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*